Related references
Note: Only part of the references are listed.HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer
Xiaofang Yi et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2009)
Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer
H-H Woo et al.
ONCOGENE (2009)
Enhanced Ovarian Cancer Tumorigenesis and Metastasis by the Macrophage Colony-Stimulating Factor
Eugene P. Toy et al.
NEOPLASIA (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Circulating colony stimulating factor-1 and breast cancer risk
Rulla M. Tamimi et al.
CANCER RESEARCH (2008)
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin Zhu et al.
CELL RESEARCH (2008)
Role of microRNAs in drug-resistant ovarian cancer cells
Antonio Sorrentino et al.
GYNECOLOGIC ONCOLOGY (2008)
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer
Sharad A. Ghamande et al.
GYNECOLOGIC ONCOLOGY (2008)
Serous carcinogenesis in the fallopian tube: A descriptive classification
Elke Jarboe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
Early events in the pathogenesis of epithelial ovarian cancer
Charles N. Landen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer
Yi Zhou et al.
MOLECULAR CANCER RESEARCH (2008)
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie et al.
NATURE (2008)
Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype
K. Mazan-Mamczarz et al.
ONCOGENE (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer
Zhen Zhang et al.
GYNECOLOGIC ONCOLOGY (2007)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis
Kwong-Kwok Wong et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Primary Fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
Michael J. Callahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)
D. S. Alberts et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
AU-rich-element-mediated upregulation of translation by FXR1 and argonaute 2
Shobha Vasudevan et al.
CELL (2007)
Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy
Rohit G. Saldanha et al.
JOURNAL OF PROTEOME RESEARCH (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts
P Paulus et al.
CANCER RESEARCH (2006)
Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype
Thorsten Hagemann et al.
JOURNAL OF IMMUNOLOGY (2006)
Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer:: A phase I trial
A Berkenblit et al.
GYNECOLOGIC ONCOLOGY (2005)
Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK
T Hagemann et al.
JOURNAL OF IMMUNOLOGY (2005)
Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-rich 3′ untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells:: Possible role in CSF-1 posttranscriptional regulation and tumor phenotype
N Bonafé et al.
CANCER RESEARCH (2005)
New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells
MA Sirover
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals
XH Xie et al.
NATURE (2005)
Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma
M Heinonen et al.
CANCER RESEARCH (2005)
RNA-binding proteins in early development
LJ Colegrove-Otero et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis
EP Toy et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture
CN Wrobel et al.
JOURNAL OF CELL BIOLOGY (2004)
An unexpected effect of glucocorticoids on stimulation of c-fms proto-oncogene expression in choriocarcinoma cells that express little glucocorticoid receptor
SK Chambers et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model
HM Kluger et al.
LABORATORY INVESTIGATION (2004)
Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
S Aharinejad et al.
CANCER RESEARCH (2004)
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis
HM Kluger et al.
CLINICAL CANCER RESEARCH (2004)
Mammary tumor induction in transgenic mice expressing an RNA-binding protein
CR Tessier et al.
CANCER RESEARCH (2004)
Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression
C Denkert et al.
CANCER RESEARCH (2004)
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions
SJ Skates et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Binding proteins for mRNA localization and local translation, and their dysfunction in genetic neurological disease
GJ Bassell et al.
CURRENT OPINION IN NEUROBIOLOGY (2004)
Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer
MM Hussain et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Role of the RNA-binding protein HuR in colon carcinogenesis
IL de Silanes et al.
ONCOGENE (2003)
Mirimostim (macrophage colony-stimulating factor; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function
T Hidaka et al.
CANCER SCIENCE (2003)
Cell-specific RNA-binding proteins in human disease
K Musunuru
TRENDS IN CARDIOVASCULAR MEDICINE (2003)
A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA
G Stoecklin et al.
ONCOGENE (2003)
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression
H Ide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Part I: Chemotherapy for epithelial ovarian cancer - treatment at first diagnosis
M Harries et al.
LANCET ONCOLOGY (2002)
Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element
MB Flick et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects
XM Dai et al.
BLOOD (2002)
Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1op/Csf1op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis
GR Ryan et al.
BLOOD (2001)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
RU-486 can abolish glucocorticoid-induced increases in CSF-1 receptor expression in primary human breast carcinoma specimens
BM Kacinski et al.
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION (2001)
HuR and mRNA stability
CM Brennan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma
EP Toy et al.
GYNECOLOGIC ONCOLOGY (2001)
Transcriptional regulation of c-fms gene expression
Y Xie et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2001)
Transcriptional regulation of the expression of macrophage colony stimulating factor
J Rubin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)